Daniel Gallego-Perez
Overview
Explore the profile of Daniel Gallego-Perez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salazar-Puerta A, Ott N, Diaz-Starokozheva L, Das D, Lawrence W, Johnson J, et al.
Bio Protoc
. 2024 Nov;
14(22):e5117.
PMID: 39600980
Adipose tissue is crucial for medical applications such as tissue reconstruction, cosmetic procedures, and correcting soft tissue deformities. Significant advances in the use of adipose tissue have been achieved through...
2.
Cuellar-Gaviria T, Rincon-Benavides M, Topsakal H, Salazar-Puerta A, Jaramillo-Garrido S, Kordowski M, et al.
J Control Release
. 2024 Nov;
376:1300-1315.
PMID: 39491627
The emergence of bacteria that are resistant to antibiotics is on track to become a major global health crisis. Therefore, there is an urgent need for new treatment options. Here,...
3.
Hoenders R, Ghelman R, Portella C, Simmons S, Locke A, Cramer H, et al.
Front Med (Lausanne)
. 2024 Jun;
11:1395698.
PMID: 38933107
Despite important progress in modern medicine, widely regarded as an indispensable foundation of healthcare in all highly advanced nations and regions, not all patients respond well to available treatments in...
4.
Ortega-Pineda L, Guilfoyle E, Rincon-Benavides M, Anaparthi A, Lemmerman L, Cuellar-Gaviria T, et al.
Adv Nanobiomed Res
. 2024 Jun;
3(10).
PMID: 38911285
Direct nuclear reprogramming has the potential to enable the development of β cell replacement therapies for diabetes that do not require the use of progenitor/stem cell populations. However, despite their...
5.
Panic A, Moore J, Gallego-Perez D
Methods Cell Biol
. 2024 Mar;
184:97-103.
PMID: 38555161
Current strategies to undermine the deleterious influence of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TME) are lacking effective clinical solutions, in large part, due to insufficient knowledge on...
6.
Salazar-Puerta A, Kordowski M, Cuellar-Gaviria T, Rincon-Benavides M, Hussein J, Flemister D, et al.
Cell Mol Bioeng
. 2023 Oct;
16(4):309-324.
PMID: 37810997
Introduction: Valvular heart disease represents a significant burden to the healthcare system, with approximately 5 million cases diagnosed annually in the US. Among these cases, calcific aortic stenosis (CAS) stands...
7.
Duarte-Sanmiguel S, Salazar-Puerta A, Panic A, Dodd D, Francis C, Alzate-Correa D, et al.
Biomater Sci
. 2023 Aug;
11(20):6834-6847.
PMID: 37646133
Tumor-associated immune cells play a crucial role in cancer progression. Myeloid-derived suppressor cells (MDSCs), for example, are immature innate immune cells that infiltrate the tumor to exert immunosuppressive activity and...
8.
Rincon-Benavides M, Mendonca N, Cuellar-Gaviria T, Salazar-Puerta A, Ortega-Pineda L, Blackstone B, et al.
Adv Ther (Weinh)
. 2023 Aug;
6(3).
PMID: 37577183
Vasculogenic cell therapies have emerged as a powerful tool to increase vascularization and promote tissue repair/regeneration. Current approaches to cell therapies, however, rely mostly on progenitor cells, which pose significant...
9.
Das D, Lawrence W, Diaz-Starokozheva L, Salazar-Puerta A, Ott N, Goebel E, et al.
J Biomed Mater Res A
. 2023 Jun;
111(11):1722-1733.
PMID: 37326365
Autologous adipose tissue is commonly used for tissue engraftment for the purposes of soft tissue reconstruction due to its relative abundance in the human body and ease of acquisition using...
10.
Salazar-Puerta A, Rincon-Benavides M, Cuellar-Gaviria T, Aldana J, Vasquez Martinez G, Ortega-Pineda L, et al.
Adv Mater
. 2023 Apr;
35(28):e2210579.
PMID: 37119468
Acute respiratory distress syndrome (ARDS) represents a significant burden to the healthcare system, with ≈200 000 cases diagnosed annually in the USA. ARDS patients suffer from severe refractory hypoxemia, alveolar-capillary...